Courses | Page 5 | AUA University

Topic

Core Curriculum Related Education

Title	Category	Credit	Event Date	Price
Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is offering phase two of an educational series to update urologists and advanced practice providers (APPs) on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. Part II will consist of two live webinars, one designed specifically for urologists and the other for APPs. The live virtual courses will feature a multidisciplinary panel engaging in a lively discussion on this topic.
Prostate Cancer Diagnosis: AUA Guidelines on use of PSA Biomarkers, MRI and Biopsy Techniques Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Prostate cancer detection remains one of the most common and most controversial aspects of urological practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications.
PARPi: Precision Medicine in Advanced Prostate Cancer Webcast (2023)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
PARPi: Management of Adverse Events Webcast (2024)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023)		1.00 AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Novel Imaging for Genitourinary Cancers – Diagnostics and Theranostics Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:
New AUA Guideline (2024): Salvage Therapy for Prostate Cancer Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The course details the 2024 AUA Guidelines for salvage therapy following initial treatment of localized prostate cancer, focusing on integral aspects of salvage treatments, risk stratification and advanced imaging. Participants will gain insights into the timing and appropriate use of salvage radiation therapy with or without androgen deprivation therapy (ADT), the use of risk stratification tools and the application of next-generation imaging in patients with biochemical recurrence.
Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	This new AUAUniversity podcast episode will address mechanisms behind infectious complications as well as the health care consequences of infections following prostate biopsy. Faculty will present real world and trial data pertaining to rates and associated factors for infections and provide practical measures to reduce these complications, including transperineal and transrectal approach (standard enema; antibiotic enema; iodine/other rectal prep; needle disinfection).
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)		1.50 AMA PRA Category 1 Credit™ 1.50 Non-Physician Participation		$0.00	Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.
Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There are multiple genomic tests and advanced imaging modalities (MRI, prostate-specific membrane antigen PET, etc.) currently available for men to detect and risk-stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc.) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc.). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling and cascade testing of family members.
How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local...		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The learners will understand the following critical clinical aspects with regard to the clinical application of prostate-specific membrane antigen (PSMA) PET/CT; scanning mode of action of PSMA PET/CT; pitfalls of PSMA PET/CT; diagnostic accuracy depending on PSA, PSA double time, prostate cancer histology; application of PSMA PET/CT to identify patients with intrapelvic nodal relapse who will benefit from local therapy such as salvage lymphadenectomy or stereotactic radiation therapy; application of PSMA PET/CT to identify patients with organ-confined radiorecurrent local relapse of prosta
Germline Testing in GU Cancers – How I Do It Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Germline Testing in GU Cancers – How I Do It (2023)
Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:
Early Detection of Prostate Cancer: AUA/SUO Guideline Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)
Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is offering phase two of an educational series to update urologists and advanced practice providers (APPs) on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. Part II will consist of two live webinars, one designed specifically for urologists and the other for APPs. The live virtual courses will feature a multidisciplinary panel engaging in a lively discussion on this topic.

Pages